CVR: 30815378
Secondary names: PEC-CPH A/S, PHARMACEUTICAL ECONSULTING - COPENHAGEN A/S, PHARMACEUTICAL E-CONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 4 employees. In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity amounted to DKK 5,152,605.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med salg af konsulentydelser og rådgivning indenfor farmaceutisk industri samt anden efter ledelsens skøn dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 6.1 mio. | -1.1 mio. | 10.6 mio. | 5.2 mio. | 0 | |
| 2024 | 5.5 mio. | -644 t. | 8.8 mio. | 6.2 mio. | 8 | |
| 2023 | 5.6 mio. | -384 t. | 8 mio. | 6.9 mio. | 8 | |
| 2022 | 6.8 mio. | 780 t. | 8.1 mio. | 7.2 mio. | 8 | |
| 2021 | 8.3 mio. | 2.4 mio. | 19.7 mio. | 6.5 mio. | 5 | |
| 2020 | 6.9 mio. | 2.3 mio. | 17.1 mio. | 4 mio. | 4 | |
| 2019 | 5.3 mio. | 1.2 mio. | 14.1 mio. | 2.7 mio. | 4 | |
| 2018 | 3.8 mio. | 1.1 mio. | 11.5 mio. | 2.5 mio. | 4 | |
| 2017 | 4.1 mio. | 1.9 mio. | 10.5 mio. | 6.4 mio. | 3 | |
| 2016 | 3 mio. | -301 t. | 8.3 mio. | 4.5 mio. | - | |
| 2015 | - | 0 | 0 | 0 | - | |
| 2014 | - | 0 | 0 | 0 | - | |
| 2013 | - | 0 | 0 | 0 | - | |
| 2012 | -1.8 mio. | 397 t. | 3.3 mio. | -1.3 mio. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.164 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2025. Gross profit came to DKK 6,113,709, and the net result was DKK -1,066,960.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2024. Gross profit came to DKK 5,538,003, and the net result was DKK -643,853.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2023. Gross profit came to DKK 5,578,646, and the net result was DKK -383,631.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2022. Gross profit came to DKK 6,778,724, and the net result was DKK 779,620.
As of March 27, 2023, Optimal Revision Godkendt Revisionsvirksomhed has been appointed auditor of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2021. Gross profit came to DKK 8,276,389, and the net result was DKK 2,419,807.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2020. Gross profit came to DKK 6,946,670, and the net result was DKK 2,345,127.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2019. Gross profit came to DKK 5,316,382, and the net result was DKK 1,210,618.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2018. Gross profit came to DKK 3,801,997, and the net result was DKK 1,055,307.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2017. Gross profit came to DKK 4,060,289, and the net result was DKK 1,928,984.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2016. Gross profit came to DKK 2,961,733, and the net result was DKK -301,438.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2015. The net result was DKK 0.
As of June 14, 2016, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of June 14, 2016, Steen Otto Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of June 14, 2016, Pernille Laurberg Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of June 14, 2016, Steen Otto Rugaard is registered as adm. dir. of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Hanne Laurberg Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Steen Otto Rugaard has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Pernille Laurberg Rugaard has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Steen Otto Rugaard has stepped down as director of PHARMACEUTICAL ECONSULTING A/S.
As of December 31, 2015, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of December 31, 2015, Jens Christian Pii Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of December 30, 2015, Hanne Laurberg Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2014. The net result was DKK 0.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2013. The net result was DKK 0.
As of April 2, 2014, Optimal Revision Godkendt Revisionsvirksomhed has stepped down as auditor of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2012. Gross profit came to DKK -1,783,587, and the net result was DKK 397,364.
As of October 1, 2007, Jens Christian Pii Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of October 1, 2007, Pernille Laurberg Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Optimal Revision Godkendt Revisionsvirksomhed has been appointed auditor of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Steen Otto Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Steen Otto Rugaard is registered as director of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, RUGAARD HOLDING ApS is registered as an owner of PHARMACEUTICAL ECONSULTING A/S with an ownership share of 100%.
PHARMACEUTICAL ECONSULTING A/S was founded on September 3, 2007.
Companies in the same industry and area
CVR 42317160
CVR 44388189
CVR 32329241
CVR 38916912
CVR 33026048
companydata.dk